Finance

Beta
Lists
IRD:NASDAQ
Opus Genetics Inc
$3.90
-0.38%
(-0.015) 1D
$3.90
+0.00% (+0.000100)
Pre-market
Closed: Jun 16, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRD...
Open
$3.91
High
$3.98
Low
$3.80
Mkt. cap
317.04M
Avg. vol.
884.24K
Volume
979.00
52-wk high
$5.81
52-wk low
$0.90
EPS
-$1.32
Beta
0.56
Shares outstanding
81.40M
No. of employees
28
Open
$3.91
High
$3.98
Low
$3.80
Mkt. cap
317.04M
Avg. vol.
884.24K
Volume
979.00
52-wk high
$5.81
52-wk low
$0.90
EPS
-$1.32
Beta
0.56
Shares outstanding
81.40M
No. of employees
28
Analyst outlook
Analyst Ratings
Based on 14 analysts giving stock ratings to IRD in the past 3 months
Strong Buy
Buy
14
Hold
0
Sell
0
12 month forecast
Based on 14 Wall Street analysts offering 12 month price targets for IRD in the last 3 months.
Highest
Current $3.90
$16.00 (+310.26%)
Average
$11.08 (+184.10%)
Lowest
$8.00 (+105.13%)
News stories
From sources across the web
About Opus Genetics Inc
CEO-
Employees28
Founded2018
Headquarters-
SectorBiotechnology
Websiteopusgtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.88M
3.08M
3.86M
2.16M
Cost of goods sold
6.02M
6.41M
10.43M
10.48M
Cost of revenue
6.02M
6.41M
10.43M
10.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.77M
4.98M
4.89M
6.04M
Operating expense
5.77M
4.98M
4.89M
6.04M
Total operating expenses
11.79M
11.39M
15.32M
16.52M
Operating income
-8.91M
-8.31M
-11.45M
-14.36M
Other non operating income
986.00K
-9.38M
-3.97M
-51.50M
EBT including unusual items
-7.42M
-17.45M
-16.52M
-65.54M
EBT excluding unusual items
-7.42M
-17.45M
-16.52M
-65.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.42M
-17.45M
-16.52M
-65.54M
Net profit margin
-257.46%
-566.87%
-427.50%
-3,038.25%
Earnings per share
-0.12
-0.25
-0.21
-0.75
Interest and investment income
500.00K
300.00K
300.00K
400.00K
Interest expense
-
-68.00K
-1.40M
-69.00K
Net interest expenses
500.00K
232.00K
-1.10M
331.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.89M
-8.30M
-11.44M
-14.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer